NLRP3 INFLAMMASOME INHIBITORS

The specification generally relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof, where R

Saved in:
Bibliographic Details
Main Authors BERGONZINI, Giulia, GRADÉN, Henrik, MATSUMURA, Takehiko, JOHANSSON, Lars Anders Mikael, SUGAMA, Hiroshi
Format Patent
LanguageEnglish
Published 08.02.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The specification generally relates to compounds of Formula (I), and pharmaceutically acceptable salts thereof, where R
Bibliography:Application Number: AU20220304254